Insulet (PODD) Stock Price, Quote, News & History | Benzinga

Insulet Corp (PODD) Stock Price, Quote, News & History

PODDNASDAQ

Trade with Public

Trade with Public

$145.42

-2.74-1.85%

At close: Aug 24, 5:00 PM EST

$145.00

-0.42-0.29%

After Hours: 4:37 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$151.17

Close

$145.42

Volume / Avg.

1.57M / 1.58M

Day Range

$145.15 - $151.75

52 Wk Range

126.40 - 354.88

Market Cap

$10.21B

P/E Ratio

27.80

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

8.29%

Days to Cover

3.03

Recent Insulet Corporation News

Paycom Software To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed EyePoint's target, Goldman cut Sunrun's, B of A lowered Coupang's, BTIG cut Klaviyo's, Jefferies raised J&J Snack Foods', Raymond James raised Select Water Solutions', and Freedom Broker raised Danaos'.

Avi Kapoor

This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. HUBS, PODD, FRPT, WTTR, REXR downgraded.

Avi Kapoor

These Analysts Slash Their Forecasts On Insulet After Q2 Results

Insulet Corp. (NASDAQ:PODD) reported strong Q2 earnings but lowered revenue outlook for 2021. Analysts downgraded stock and lowered price targets.

Avi Kapoor

Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool inflation fears.

Piero Cingari

Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff

Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 revenue guidance. Get details here.

Kaustubh Bagalkote

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

511.20M

Investing Cash Flow (TTM)

-248.90M

Financing Cash Flow (TTM)

-845.40M

Free Cash Flow (TTM)

265.60M

Capital Expenditure (TTM)

-245.60M

Net Change in Cash (TTM)

-583.10M

Analyst Trends and Forecast

13

2

1

May

2

Jun

4

2

Jul

5

5

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$10.69B

PE Ratio (TTM)

27.80

PE Ratio (FWD)

24.51

PEG Ratio (TTM)

1.49

PS Ratio (TTM)

3.47

PB Ratio (TTM)

7.23

Earnings Yield % (TTM)

3.60%

Earnings Yield % (FWD)

4.08%

EV / EBITDA (TTM)

16.37

Price / EBITDA (TTM)

16.22

Price / Free Cash Flow (TTM)

39.87

Book Value / Share

$20.51

Company Debt

Total Debt

$948.40M

LT Debt

$929.50M

LT Debt Issuance (TTM)

$13.80M

LT Debt Repayment (TTM)

-$622.80M

Total Cash

$534.90M

Debt to Equity

0.67

Issuance of Debt (TTM)

-$609.00M

Repayment of Debt (TTM)

-$622.80M

Key Statistics

Open

$151.17

Close

$145.42

Volume / Avg.

1.57M / 1.58M

Day Range

$145.15 - $151.75

52 Wk Range

126.40 - 354.88

Market Cap

$10.21B

P/E Ratio

27.80

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

8.29%

Days to Cover

3.03

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated thro...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Insulet (PODD) stock?

A

You can purchase shares of Insulet (NASDAQ:PODD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Insulet (PODD) competitors?

A

Other companies in Insulet’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Insulet (PODD) stock?

A

Insulet has a consensus price target of $244.87.

Q

What is the current price for Insulet (PODD)?

A

The stock price for Insulet (NASDAQ: PODD) is $145 last updated August 24, 2026 at 4:37 PM EDT.

Q

Does Insulet (PODD) pay a dividend?

A

There are no upcoming dividends for Insulet.

Q

When is Insulet (NASDAQ:PODD) reporting earnings?

A

Insulet does not have any upcoming earnings scheduled.

Q

Is Insulet (PODD) going to split?

A

There is no upcoming split for Insulet.

Q

What sector and industry does Insulet (PODD) operate in?

A

Insulet is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.